174 related articles for article (PubMed ID: 1517579)
1. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody.
Stull SJ; Sharp GC; Kyriakos M; Bickel JT; Braley-Mullen H
J Immunol; 1992 Sep; 149(6):2219-26. PubMed ID: 1517579
[TBL] [Abstract][Full Text] [Related]
2. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Kyriakos M
J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
[TBL] [Abstract][Full Text] [Related]
4. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC
J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592
[TBL] [Abstract][Full Text] [Related]
5. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
Peterson KE; Braley-Mullen H
J Autoimmun; 1999 Feb; 12(1):1-12. PubMed ID: 10028017
[TBL] [Abstract][Full Text] [Related]
6. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids.
Tang H; Sharp GC; Peterson KP; Braley-Mullen H
J Immunol; 1998 May; 160(10):5105-12. PubMed ID: 9590262
[TBL] [Abstract][Full Text] [Related]
8. Induction of granulomatous experimental autoimmune thyroiditis in IL-4 gene-disrupted mice.
Tang H; Sharp GC; Peterson KE; Braley-Mullen H
J Immunol; 1998 Jan; 160(1):155-62. PubMed ID: 9551967
[TBL] [Abstract][Full Text] [Related]
9. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.
Zhang W; Flynn JC; Kong YC
Cell Immunol; 2001 Feb; 208(1):52-61. PubMed ID: 11277619
[TBL] [Abstract][Full Text] [Related]
10. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody.
Braley-Mullen H; Sharp GC; Bickel JT; Kyriakos M
J Exp Med; 1991 Apr; 173(4):899-912. PubMed ID: 1672546
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis.
Braley-Mullen H; Sharp GC; Tang H; Chen K; Kyriakos M; Bickel JT
Am J Pathol; 1998 May; 152(5):1347-58. PubMed ID: 9588903
[TBL] [Abstract][Full Text] [Related]
12. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells.
Tang H; Mignon-Godefroy K; Meroni PL; Garotta G; Charreire J; Nicoletti F
Eur J Immunol; 1993 Jan; 23(1):275-8. PubMed ID: 8419180
[TBL] [Abstract][Full Text] [Related]
13. T cell receptor V beta usage in murine experimental autoimmune thyroiditis.
McMurray RW; Hoffman RW; Tang H; Braley-Mullen H
Cell Immunol; 1996 Aug; 172(1):1-9. PubMed ID: 8806800
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of cytokine gene expression in the thyroids of mice developing granulomatous experimental autoimmune thyroiditis.
Tang H; Sharp GC; Chen K; Braley-Mullen H
J Autoimmun; 1998 Dec; 11(6):581-9. PubMed ID: 9878080
[TBL] [Abstract][Full Text] [Related]
15. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin.
Peterson KE; Braley-Mullen H
Cell Immunol; 1995 Nov; 166(1):123-30. PubMed ID: 7585972
[TBL] [Abstract][Full Text] [Related]
16. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.
Nabozny GH; Kong YC
J Immunol; 1992 Aug; 149(3):1086-92. PubMed ID: 1634763
[TBL] [Abstract][Full Text] [Related]
17. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development.
Stull SJ; Kyriakos M; Sharp GC; Braley-Mullen H
Cell Immunol; 1988 Nov; 117(1):188-98. PubMed ID: 2902931
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta has contrasting effects in the presence or absence of exogenous interleukin-12 on the in vitro activation of cells that transfer experimental autoimmune thyroiditis.
Fondal W; Sampson C; Sharp GC; Braley-Mullen H
J Interferon Cytokine Res; 2001 Nov; 21(11):971-80. PubMed ID: 11747629
[TBL] [Abstract][Full Text] [Related]
19. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
Tang H; Braley-Mullen H
Int Immunol; 1997 May; 9(5):679-87. PubMed ID: 9184913
[TBL] [Abstract][Full Text] [Related]
20. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis.
Peterson KE; Sharp GC; Tang H; Braley-Mullen H
J Immunol; 1999 Feb; 162(3):1859-67. PubMed ID: 9973452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
